Biocompatible, Multiresponsive Nanogel Composites for Codelivery of Antiangiogenic and Chemotherapeutic Agents by Strozyk, MS et al.
 1 
Biocompatible, multiresponsive nanogel 
composites for co-delivery of anti-angiogenic 
and chemotherapeutic agents 
Malte S. Strozyk,† Ɨ Susana Carregal-Romero,†  
Malou Henriksen-Lacey†,∥, Mathias BrustƗ, Luis M. Liz-Marzán*,†,‡,∥ 
 
†Bionanoplasmonics Laboratory, CIC biomaGUNE, Paseo de Miramón 182, 20014 Donostia-San Sebastián, 
Spain 
ƗDepartment of Chemistry, University of Liverpool, Liverpool L69 7ZD, United Kingdom 
‡Ikerbasque, Basque Foundation for Science, 48013 Bilbao, Spain 
∥CIBER de Bioingeniería, Biomateriales y Nanomedicina, CIBER-BBN, 20014 Donostia-San Sebastián, 
Spain 
*e-mail: llizmarzan@cicbiomagune.es 
 
 
ABSTRACT  
Single therapy approaches are usually insufficient to treat certain diseases, due to 
genetic differences between patients or disease resistance. Therefore, such 
approaches are gradually replaced by combination therapies comprising two or more 
drugs. In oncology these include BRAF inhibitors, cytotoxic, anti-angiogenic or 
immunomodulatory agents, among others. We propose herein the use of 
multiresponsive nanogel composites for the co-delivery of a DNA intercalator 
(doxorubicin) and an anti-angiogenic and immunomodulatory agent (pomalidomide). 
We introduce a surfactant-free synthetic protocol to decorate biocompatible 
poly(ethylene glycol)methacrylate nanogels (PEGMA) with evenly distributed gold 
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nanoparticles and explore their ability to deliver drugs upon stimulation by various 
triggers such as heat, light and reducing agents present in the intracellular 
environment. We further demonstrate that an additional polymer coating on the 
nanogel surface can decrease uncontrolled drug leakage, and modulate cellular 
uptake and the drug release profile.  
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INTRODUCTION 
 
Chemotherapy still prevails as the most common treatment for cancer. However, there is a 
rising demand for alternative therapies, which involve the use of anticancer drugs combined 
with other molecularly target agents toward the reduction of side effects and the 
enhancement of the treatment efficacy.1,2 The use of nanoparticles (NPs) for drug delivery 
is a well recognized method to control the delivery kinetics and biodistribution of the drug 
in question, as well as offering protection from biological conditions which can cause drug 
degradation.3–7 Furthermore, NP materials need not be limited to one sole material or be 
loaded with a single drug. In fact, this leads to many possibilities in terms of triggered, 
controlled, drug release and co-delivery that can be combined with multimodal imaging.8–11 
Regarding chemotherapy, NPs offer the possibility to improve treatment efficacy by 
delivering cytotoxic drugs to cancerous cells with minimal exposure to non-cancerous cells, 
thereby avoiding chemotherapy side effects.12–15 Tumors, however, are complex structures 
and their growth promotes angiogenesis in an autocrine manner, thereby allowing a 
constant supply of nutrients and oxygen to the cancerous cells.16–18 The suppression of 
tumor growth by action of anti-angiogenic agents is therefore an appealing method to target 
cancer.19,20 One of the most interesting aspects therefore of NPs is their ability to deliver a 
combination of drugs which can target different aspects of tumour growth and persistence. 
One such example of this is Doxil, a liposomal doxorubicin carrying NP system, which has 
been combined with dexamethasone and pomalidomide and is currently in clinical trials to 
treat Multiple Melanoma (MM) cancer (NCT01541332 from www.clinical trials.gov). 
In this context, we propose the use of nanogels for combination therapy and controlled 
release of drugs. Nanogels are formed by crosslinked polymeric networks that possess a 
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 4 
large water content and open spaces with a characteristic mesh size. The mesh size governs 
the diffusion of drugs within the nanogel and the chemical interaction between the polymer 
structure determines the drug entrapment efficiency.21,22 Nanogels show several advantages 
over other drug carrier systems, which are related with the mild conditions of drug 
encapsulation, which allow entrapment of labile drugs (hydrophilic and hydrophobic), their 
excellent biocompatibility and the easy tailoring of their responsiveness toward triggers of 
drug release.23,24 In contrast, the main drawback is the uncontrolled leakage of drugs. The 
nanogel polymer chemistry can be designed to release cargo molecules upon different 
stimuli such as e.g. pH or heat.25 By including gold (Au) NPs within the nanogel, near-
infrared (NIR) illumination can be used to induce local heating at the AuNP surface, 
thereby providing a further trigger for drug release and offering NP-based 
hyperthermia.26,27 Importantly, the use of NIR illumination renders such a system suitable 
for use in biological tissues, due to the reduced absorption by tissue of light with 
wavelength between 650 and 950 nm.28  
In this proof of concept work we demonstrate that AuNP-containing thermosensitive 
nanogels, coated with an appropriate polyelectrolyte, are suitable platforms for the co-
delivery of doxorubicin (Doxo) – a cytotoxic agent and DNA intercalator – and 
pomalidomide (Poma) – an anti-angiogenic and immunomodulatory agent.29–31 These 
drug delivery systems are preferentially cytotoxic to cancer cells in vitro, while also being 
efficient at inhibiting angiogenesis in tube-formation assays in vitro. Nanogels are a highly 
versatile system in which drug release profiles can be controlled via polyelectrolyte coating 
and/or various external stimuli, showing good biocompatibility and biodegradation in vitro. 
The final nanogels thus offer a stable platform that can be prepared by straightforward 
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 5 
production methods and used to deliver several drugs, with both hyperthermia and 
photothermal ablation therapy characteristics.  
 
RESULTS AND DISCUSSION 
Formation of polyelectrolyte coated AuNP decorated PEGMA nanogels 
The thermoresponsive nanogels used for the loading and co-delivery of the two 
selected drugs were based on poly(ethylene glycol) methyl ether methacrylate 
(PEGMA), and formed by the well-established free radical polymerization 
method.32–34 PEGMA nanogels were chosen because of their easy-to-tailor lower critical 
solution temperature (LCST), ranging from room temperature up to 90 ºC,35,36 and 
because their monomer constituents are non-toxic.37 These are two major advantages, as 
compared e.g. to the widely used poly(N-isopropyl acrylamide) (pNIPAM).38,39 In the 
second step of the synthesis, a surfactant-free method was used to incorporate light 
responsive (plasmonic) AuNPs within the PEGMA nanogels, thereby avoiding potential 
toxicity of surfactants and keeping the AuNPs surface free to adsorb other molecules 
(Figure 1a). To this purpose, pre-made nanogels were immersed in a solution of HAuCl4, 
followed by addition of a strong reducing agent, NaBH4. The amino groups in the nanogels 
(present in the monomer 2-aminoethyl methacrylate hydrochloride) coordinate the gold 
precursor and small gold seeds of approximately 3 nm were formed upon NaBH4 reduction. 
These seeds were subsequently grown by addition of HAuCl4, sodium bromide and 
formaldehyde, which displays a pH-dependent reducing potential.40 Sodium bromide 
helped in controlling AuNP growth due to the formation of a gold bromide complex with 
higher stability as compared to free HAuCl4. When the process was carried out, in the 
absence of either Au seeds or sodium bromide, nanogels were obtained with particle 
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 6 
disparity, anisotropy and aggregation (Figure S1, Supporting Information). On the 
contrary, seeded growth produced nanogels with evenly distributed AuNPs with an average 
size of 23.2 ± 6.1 nm and a low proportion of anisotropic particles (Figure 1b). The 
nanogel containing AuNPs displayed a localized surface plasmon resonance (LSPR) band 
centered at 540 nm (Figure 1c), which is redshifted with respect to free AuNPs with similar 
sizes due to some anisotropy and plasmon coupling between the AuNPs in the gel. This 
two-step process allows a good level of control over the final AuNP size, which can range 
from 9 to 30 nm simply by tuning the amount of Au seed-loaded nanogels added to the 
growth solution (Figure S2). PEGMA nanogels were subsequently wrapped with 
biodegradable and biocompatible polyelectrolytes to modify the release profile of 
encapsulated drugs, and to add a coating that can easily bind other functional moieties 
(such as antibodies or dyes) for future applications.41 Functionalization was carried out by 
immersing AuNP-loaded nanogels in the appropriate polyelectrolyte solution followed by 
several washing steps to remove non-adsorbed polyelectrolytes. Samples with different 
surface compositions were named as follows: 1) AuNG1 had no coating, 2) AuNG2 was 
coated with poly-L-arginine and 3) AuNG3 was coated with polyalginate. We studied the 
influence of the two different coatings, i.e. the polypeptide poly-L-arginine and the 
polysaccharide polyalginate, on the physicochemical properties of the nanogels, and their 
drug loading and release profiles for both Doxo and Poma. 
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Figure 1. a) Schematic representation of the in-situ growth of gold nanoparticles in PEGMA nanogels. Small gold seeds 
were synthesized by reduction with NaBH4. Further growth was realized by introducing the nanogels with seeds in a 
growth solution containing NaBr and formaldehyde at high pH. The obtained nanogels were finally wrapped with a layer 
of polyelectrolyte. b) Representative TEM pictures of the nanogels during the different growth steps, as labeled. c) UV-
Vis spectra of the corresponding particle colloids. 
 
Influence of polyelectrolyte coatings on the physicochemical properties of PEGMA 
nanogels 
The presence of the polyelectrolytes on PEGMA nanogels was confirmed by X-ray 
photoelectron spectroscopy (XPS), zeta potential, LSPR and particle size analysis. XPS 
data showed a clear decrease in the amount of Au on the nanogel surface between coated 
and non-coated nanogels. Additionally, nitrogen was identified in sample AuNG2 due to 
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the amino groups in poly-L-arginine, whereas AuNG3 showed a higher amount of oxygen 
due to the hydroxyl and carboxyl groups in polyalginate, as compared with AuNG1. 
Changes in zeta potential, LSPR and particle size were also observed, as shown in Table 1. 
AuNG2 was found to become more compact upon polyelectrolyte addition, which in turn 
reduced the AuNP interparticle distance inside the nanogels, resulting in stronger plasmon 
coupling and a LSPR red shift of 23 nm after functionalization (Figure 1b,c). The decrease 
in overall nanogel size observed in AuNG2 is due to the strong electrostatic interaction 
between the negatively charged nanogel and the positively charged polyelectrolyte, which 
results in the formation of a polyelectrolyte-gel complex.42 It has been reported that, if the 
molecular weight of the coating molecules is low enough they can even penetrate the 
nanogel reducing the mesh size.43 In contrast, functionalization with the anionic 
polyalginate did not modify the LSPR but caused slight swelling of the nanogel, 
presumably due to the weaker interactions between polyalginate and the nanogel.  
 
Table 1. Differences in elemental composition, LSPR, zeta potential (ζ) and hydrodynamic diameter (Dh) of the coated 
and non-coated PEGMA nanogels. 
 
Sample N (at.%) C (at.%) O (at.%) Au (at.%) LSPR (nm) ζ (mV) Dh (nm) 
AuNG1 0 64.3 24.8 10.9 544 -36.2 ± 0.2 274.1 ± 2.0 
AuNG2 11.1 56.3 27 5.6 567 40.9 ± 0.3 223.8 ± 1.4 
AuNG3 0 46.9 49.6 3.5 544 -34.5 ± 0.8 292.1 ± 4.4 
 
In the context of physicochemical changes, it is worth highlighting the strong influence of 
polyelectrolyte coatings on the thermoresponsive behavior of PEGMA nanogels. Bare 
nanogels displayed a LCST above 30 ºC (Figure S11) and the inclusion of AuNPs inside 
the nanogels did not hinder their ability to shrink or swell in response to heat changes 
(Figure 2a). In contrast, we noted significant differences in the swelling ratios (Q) 
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 9 
depending on the type of polyelectrolyte coatings. Q was defined as the ratio between the 
volume of the corresponding nanogel at a temperature T versus the volume at 70 ºC 
(Q=V(T)/V(70 ºC)). Figure 2b illustrates the observed decrease in Q for coated PEGMA 
nanogels. The largest decrease of Q between coated and non coated nanogels was observed 
for AuNG2, which almost completely lost its thermoresponsiveness. This result is in 
agreement with the reduction in particle size upon coating with poly-L-arginine. 
Interestingly, the LCST increased from 32 ºC in AuNG1 to 36 ºC and 37 ºC for AuNG2 and 
AuNG3 respectively, closer to physiologically relevant temperatures.  
 
Figure 2. a) Schematic representation of the shrinking process and representative TEM pictures in collapsed and swollen 
states. b) Dynamic light scattering monitoring of the swelling ratio in AuNGs. c) UV-Vis spectra of the nanogels, 
alternating at 20 ºC and 50 ºC, plotted as solid and dashed lines, respectively. The insets show the LSPR maxima during 
each cycle.  
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These results were confirmed with UV-Vis spectroscopy. As expected, the 
thermoresponsive decrease in the volume of the nanogel led to smaller inter-particle 
distances and hence to a red shift and broadening of the LSPR band. AuNG1 and AuNG3 
behave similarly, with an approximate red shift of 14 nm between 20 and 50 ºC. We 
verified the reversibility of the shift by carrying out multiple heating/cooling cycles. The 
shift was fully reversible over 5 temperature cycles (Figure 2c, inset). AuNG2, in contrast, 
shows no change of the LSPR, in accordance with the low Q value (Q= 1.1). Interestingly, 
the thermoresponsive behavior of coated PEGMA nanogels was observed to further change 
after encapsulation of drugs, in such a way that AuNG2 recovered its thermal 
responsiveness (Figure 3a). Further detailed information about the thermal behavior of 
different formulations of PEGMA nanogels has been included in the Supporting 
Information.  
In addition to the described physicochemical differences, the colloidal stability between 
coated and non-coated PEGMA nanogels was studied by incubating them in different 
media of biological interest and analyzing the corresponding values of LSPR maxima and 
zeta potential.44 AuNG3 displayed higher colloidal stability in non-supplemented cell 
culture media as compared with AuNG1 and AuNG2, which aggregated due to the high 
ionic strength, as previously reported for different polymer coated AuNPs. All PEGMA 
nanogels showed colloidal stability in cell culture media supplemented with serum due to 
protein adsorption (data shown in the Supporting Information).45  
 
Influence of polyelectrolyte coatings on stimulated drug delivery 
Drug loading was achieved by immersing AuNP decorated PEGMA nanogels in an 
aqueous solution of drugs in basic conditions, and quantified by the decrease of drug 
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concentration in solution after loading. The maximum loading of Doxo was 0.33 
mol/mg(Au) for AuNG1 and AuNG3, and 0.30 mol/mg(Au) for AuNG2. The encapsulation 
of Poma was less efficient with only 0.025 mol/mg(Au) for AuNG1, 0.019 mol/mg(Au) for 
AuNG2 and 0.020 mol/mg(Au) for AuNG3. For the sake of simplicity we discuss in the 
main text the loading and release behavior of Doxo alone, though a similar analysis was 
carried out for Poma and is discussed in the Supporting information. The entrapment of 
drugs was possible due to attractive interactions between Au decorated PEGMA nanogels 
and Poma and Doxo. Both electrostatic interactions and hydrogen bonding may be involved 
in the loading of the nanogels, due to the presence of carbonyl and ester groups in the 
nanogel and amino groups in both drugs.46 In fact, a change in the zeta potential of the 
nanogels toward more positive values after drug encapsulation was observed, as previously 
reported for similar nanogels.47 Figure 3 shows the influence of polyelectrolyte presence 
on Doxo release from PEGMA nanogels, as a function of increasing temperature. Both 
polyelectrolytes shifted the thermal release to temperatures above 37 ºC, as compared to the 
non-coated AuNG1 (Figure 3a). However, poly-L-arginine (AuNG2) hindered more the 
uncontrolled leakage of Doxo from the nanogel compared to polyalginate (AuNG3), but 
also made PEGMA nanogels less efficient at thermally triggered release. Figure 3b shows 
an 18-fold increase for AuNG3 but only a 5-fold increase for AuNG2, of released Doxo 
between room temperature and 50 ºC. 
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Figure 3. a) Dynamic light scattering measurements showing the correlation between the decrease in the swelling ratio 
(solid lines) of AuNG1, AuNG2 and AuNG3 and the increase in Doxo release (dashed lines) with the increase of 
temperature. b) Cumulative Doxo release over time at room temperature (solid lines) and at 50 ºC (dashed lines). 
 
Near-infrared (NIR) light, glutathione (GSH) and pH were also confirmed to trigger the 
release of drugs from AuNP decorated PEGMA nanogels, via different mechanisms 
(Figure 4a-c). The interaction of NIR light with AuNPs inside the nanogels led to 
shrinkage and in turn remotely controlled release of drugs due to the photothermal effect. 
Upon continuous NIR illumination (808 nm, 8.3 W/cm2), an initial increase in both the 
recorded temperature and Doxo release were noted, followed by a plateau in both 
measurements after ca. 10 minutes (Figure 4a).  
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Figure 4. a) Temperature increase (open circles) of AuNG3 solution under NIR illumination (808 nm, 8.03 W/cm2) and 
the corresponding doxorubicin release (filled circles). b) Doxo release from AuNG3 upon heating and/or GSH addition 
and corresponding SERS spectra (inset). SERS spectra were recorded in solution at a concentration of 5 µg/mL(Au), 
Plaser= 12mW for 633 nm and tint=20s with a 10x objective (NA=0.35). The assigned band at 1420 cm-1 is highlighted with 
a grey background. c) pH influence on the release of Doxo at different [GSH]. d,e) Summary of the different Doxo release 
efficiencies comparing the delivery at room temperature (control) versus the delivery upon the application of external 
stimuli, NIR light and heat (50 ºC) in solutions mimicking the extracellular (d) and intracellular environment (e). 
 
The mechanism of drug release triggered by heating (including NIR light irradiation) and 
subsequent nanogel shrinkage can be related to the removal of hydrogen bonding between 
the drugs and the nanogel itself, but also to the decrease in the radius of the nanogel and 
shortening of the diffusion path for entrapped drugs. In contrast, drugs that are released 
through reduced temperature induced swelling of nanogels have been shown to diffuse 
faster when the mesh size of the hydrogel increases due to hydrogen bonding with water 
molecules.48,49 It should be noted that, realistically, the required temperature decrease is 
hard to achieve in biological systems. The release mechanism of Doxo and Poma at 
different temperatures from AuNG2 and AuNG3 was analyzed using the semi-empirical 
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Peppas model,50 obtaining in both cases values of the release exponent n corresponding to 
the anomalous transport regime (0.43<n<0.85), which represents a mixture between 
diffusion-controlled release and other mechanisms (see Supporting Information).  
GSH was also found to enhance drug release from AuNP decorated PEGMA nanogels. This 
trigger is of interest for intracellular drug delivery since its concentration is over 200 fold 
higher within cells (0.2-10 mM) than in the extracellular environment (2-20 µM).51,52 To 
compare the GSH triggered Doxo release with that induced by heating, we exploited the 
ability of AuNPs to induce surface enhanced Raman scattering (SERS). SERS was used to 
identify Doxo within the AuNG3 nanogel after incubation with GSH, after heating and after 
both heating and GSH incubation, and the signals were compared to the corresponding 
fluorescence intensity of Doxo delivered to the supernatant from the nanogel. Figure 4b 
shows that both GSH and heat triggered the release of Doxo from the nanogel, and both 
triggers, acting in synergy, released 1.8 times more than the sum of the two triggers 
separately (30 min incubation time, T= 50 °C, [GSH]= 5 mM). The presence of Doxo was 
monitored using the characteristic SERS peak at 1420 cm-1 (corresponding to the C-O-H 
and C-H bending mode). The temperature increase enhanced the signal of Doxo as 
compared with the control experiment at room temperature, due to shortening of the inter-
particle distances, which is known to induce a further enhancement of the Raman signal. 
However, upon application of both T increase and GSH, the Doxo signal vanished faster 
than by only heating. The release mechanism of GSH could be related to ion 
displacement,23 since it is known that GSH adsorbs onto AuNPs and polymers and can 
trigger this kind of release mechanism intracellularly.53,54 In addition, we observed 
degradation and disassembly of the Au decorated PEGMA nanogels, both after GSH 
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exposure in solution and in in vitro experiments, which would subsequently enhance drug 
release (Supporting Information).  
pH changes affect hydrogen bonding,55 as well as charges on amino and carboxylic groups 
in the nanogels. As pH is also known to considerably decrease during the endocytotic 
pathway in cells, we studied the effect of pH on the release of Doxo from the nanogels. By 
exposing AuNG3 to pH 7.4 or pH 5.5, values that are representative of the extracellular and 
intracellular environment respectively, we noted a 2-fold increase in Doxo release. 
Additionally, the increased Doxo release at low pH was more pronounced in the presence 
of GSH at the usual concentrations in the intracellular environment (Figure 4c). We 
subsequently compared how all the aforementioned triggers can affect drug release in an 
environment mimicking both extracellular and intracellular conditions. Figure 4d,e shows 
that intracellular conditions enhance Doxo release induced by both heat and NIR 
illumination. Moreover, the polyelectrolytes on the nanogels surface caused significantly 
different drug release profiles, AuNG2 being more efficient in avoiding drug leakage, 
whereas all triggers enhanced drug release from AuNG3. We therefore conclude that 
AuNG3 appears to release higher amounts of Doxo, yet AuNG2 releases the same drug in a 
more controlled way under the effect of different triggers (Figure S14). A similar study 
was carried out for the release of Poma (Figure S14). In this case, release was more 
significantly affected at intracellular conditions (high [GSH] and low pH) than by the 
application of external stimuli. AuNG2 were more efficient in releasing Poma than AuNG3 
and uncontrolled leakage was similar for both types of nanogels. The different release 
profiles shown in our work are key when selecting the appropriate carrier for a specific 
drug that could demand a faster release or which is very toxic and should be only released 
at the target cells. 
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Modulation of cellular uptake in vitro 
Polyelectrolyte shells on AuNG2 (poly-L-arginine) and AuNG3 (polyalginate) were 
shown to affect nanogel uptake by both cancer and non-cancer cells, due to the different 
composition and surface charge of the nanogels. Taking into consideration that the 
increased metabolic activity of cancer cells compared with non-cancer cells can be 
exploited to improve nanogel uptake,56–58 we conducted a co-culture of HeLa cancer cells 
with healthy human dermal fibroblasts (HDF) to determine the differences in nanogel 
endocytosis. Using fluorescence microscopy and TEM we observed higher levels of 
endocytosis for AuNG2, as compared to AuNG3 (Figure 5). Flow cytometry determined 
the levels of AuNG2 and AuNG3 uptake in this co-culture, measured 24 h after a short 2 h 
incubation. The percentages of HDF cells positive for Doxo (used as a fluorescent label) 
were 75.6% and 33.7% for AuNG2 and AuNG3 nanogels, respectively, whereas the 
percentage of HeLa cells positive for Doxo were 99.4% and 75.6% for AuNG2 and 
AuNG3, respectively. This shows significant differences in cell specificity which can 
indeed be ascribed to the enhanced metabolic rates of cancer cells, as well as increased 
levels of AuNG2 uptake compared to AuNG3, due to the overall cationic charge of the 
AuNG2 system. Cationic nanoparticles and also molecules with overall positive charges 
(e.g. cell penetrating peptides) are well known to associate with cell membranes to higher 
levels than their anionic counterparts. As expected, incubation of cells (both cancerous and 
healthy) with free Doxo resulted in rapid nuclear localization, whereas Doxo containing 
AuNG2 and AuNG3 were localized in endosomes (Figure 5a,b). Similar results were 
obtained with breast cancer MCF-7 cells (Figure S19), in agreement with previous 
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studies.56 However, such increased levels of uptake in cancer cells did not correlate with 
higher drug release in vitro (Figure 6). 
 
Figure 5. a) Cellular uptake of free Doxo, AuNG2 and AuNG3 nanogels. A co-culture of HeLa (unstained) and HDF 
(blue stained) cells were exposed to Doxo and Doxo containing AuNG2 and AuNG3 for 2 h and uptake visualized using 
Doxo fluorescence (shown in red in main images or in white in inserts for clarity). Clear nuclear (left image) or 
endosomal staining (middle and right images) is seen after free or nanogel delivered Doxo, respectively. Scale bars are 
100 µm. b) TEM images of HeLa cells exposed to AuNG2 and AuNG3 for 2 h and then processed the following day for 
TEM imaging. Magnified photos are shown in color coded boxes.  
 
Modulation of co-delivery in vitro 
The effect of the two drugs Poma and Doxo was measured separately because they affect 
cells through different molecular mechanisms. We first verified that the increased levels of 
AuNG-PEGMA nanogel uptake by cancer cells compared to non-cancer cells resulted in 
downstream cell death. As seen in Figure 6a, whilst free Doxo resulted in cell death of 
both cancer and non-cancer cells in the co-culture system, exposure to Doxo-containing 
AuNG2 and AuNG3 caused predominate cytotoxicity to cancerous HeLa cells whilst HDF 
cells remained viable. The presence of Poma within the nanogels was verified as not 
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inducing any cytotoxic effects (Figure S20). The high levels of cytotoxicity noted in HeLa 
cells was slow, occurring ca. 4 days after the initial exposure of the cells to the AuNG-
PEGMA nanogels. We subsequently investigated the use of NIR light as a method to 
improve Doxo release and subsequent cell death, compared to non-illuminated controls. 
NIR-light illumination of HeLa cells incubated with AuNG-PEGMA nanogels resulted in a 
significant decrease in the viability over the non-illuminated cells (Figure 6b). Non-Doxo 
loaded nanogels (AuNG*) were used as second control, showing that it was possible to 
induce hyperthermia with AuNP-PEGMA nanogels, which is interesting for combined 
therapy as previously reported for other drug delivery systems.59 However, we verified that 
there exists an enhancement of Doxo release under NIR light illumination in vitro when 
lower power densities are applied, thereby avoiding hyperthermia (Figure S21).  
 
Figure 6. a) Live/Dead staining of HeLa/HDF co-cultures, ca. 4 days post initial exposure to free Doxo, or Doxo-
containing AuNG2 and AuNG3. Live cells show green-channel fluorescence whilst dead cells uptake propidium iodide 
and are positive for red channel fluorescence. The predominant live population (green) are HDF cells which can be 
identified by their characteristic shape, whereas HeLa cells are the majority “dead” population. Scale bars are 200 µm. b) 
NIR-laser induced hyperthermia and photo-thermal-induced cytotoxicity of HeLa cells. HeLa cells were exposed to Doxo-
containing AuNG2 and AuNG3, or non-Doxo control nanogels (AuNG*) for ca. 12h, followed by illumination with an 
Page 18 of 34
ACS Paragon Plus Environment
Chemistry of Materials
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
 19 
808 nm diode laser at 16 W/cm2 for 20 minutes. Cell viability was measured the following day using the MTT assay 
(mean of triplicate wells +- SD). 
 
The drug Poma has been shown to be highly efficient at inhibiting angiogenesis,31 in 
addition to a wide variety of immune system modifying effects such as the inhibition of 
cytokine production in LPS-stimulated peripheral blood mononuclear cells (PBMCs),60 
thereby placing it in the group of immunomodulatory drugs (IMiDs).61 We took advantage 
of these immunomodulatory effects as a method to verify that Poma remained active after 
release from AuNG nanogels. In order to do so, we exposed LPS-stimulated J774 murine 
monocyte-macrophage cells to AuNG2 and AuNG3, containing Poma alone or Doxo and 
Poma, and determined the levels of IL-6 cytokine produced. Compared to non-exposed 
controls, IL-6 levels were reduced by 90%, similar to exposure to free Poma (Figure S22). 
No significant differences in the ability of AuNG2 and AuNG3 to inhibit LPS-induced IL-6 
were observed, nor did the presence of Doxo in the formulations hinder Poma. We next 
investigated the ability of Poma containing nanogels to inhibit angiogenesis in an in vitro 
tube formation model. Due to the short time span of the assay (“tubes” form within hours 
and cells die naturally at approximately 24 h post planting), we pre-incubated HUVEC cells 
with Poma-containing nanogel formulations overnight, and the following day we planted 
the nanogel-containing HUVEC cells on the tube-inducing gel support. Figure 7a shows 
the effective inhibition of tube formation when healthy HUVEC cells, otherwise capable of 
tube formation, were pre-incubated with both Poma- containing AuNG2 or AuNG3, at a 
concentration equivalent to 10 µM. On the contrary, HUVEC cells pre-incubated with Au 
decorated PEGMA nanogels without Poma were able to form tubes (Figure S23), as 
expected. In addition to Poma effects on HUVEC cells when grown under angiogenesis-
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stimulating conditions, the cell surface area and the aspect ratio (AR) of HUVEC cells were 
significantly reduced upon exposure to Poma-containing nanogels when grown under 
“normal” tissue culture conditions (Figure 7b,c). IMiD compounds have been shown to 
activate GTPases, enzymes which are responsible for cellular cytoskeleton reorganization, 
cellular differentiation and movement.62 In fibroblasts, Poma has been shown to induce 
formation of actin stress fibers,62 and changes of cell area and aspect ratio have been 
documented upon exposure of cells to both anti- and pro-angiogenic molecules.63,64 
Considering that the production of pro-angiogenic molecules such as VEGF and bFGF is 
inhibited by a cascade of signaling pathways due to pomalidomide’s ability to down-
regulate cell adhesion molecules and reduce VEGF, bFGF and IL-6 secretion,65 it is 
reasonable to assume that Poma will affect cell surface area. Exposure of HUVEC cells to 
Poma-containing nanogels resulted in a decrease in cell size, reducing the surface area by 
1/3 – 2/3 of the original value. The decrease in cell surface area and aspect ratio was more 
pronounced for Poma-containing AuNG2 than for AuNG3, which can be correlated with an 
enhanced cell uptake of these nanogels, but also with the higher degree of Poma release 
observed in solution. Interestingly, we did not observe any similar effects upon exposure of 
HUVEC cells to free Poma, which suggests that these IMiD mediated changes in cell 
morphology are highly dependent on exposure time and subsequent Poma release from 
nanogel formulations.  
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Figure 7. a) The angiogenesis tube formation assay shows the ability of HUVEC cells to grow vessel-like interconnecting 
networks through the aid of growth factors present in the underlying gel. In cases were no nanogels were applied (1), 
established tube formation is seen within 6 h, yet with HUVEC cells pre-incubated with AuNG2 (3), or AuNG3 (4), or 
HUVEC cells incubated with free pomalidomide (2), poor or no tube-formation is seen. Each image (circle) is 4 mm in 
diameter showing the whole well. b) HUVEC cells incubated with free Poma, AuNG2 or AuNG3 for 4 h at a final Poma 
concentration of 10 µM. Cells were washed, fixed and stained with Dapi and AF488-phalliodin to show the nucleus and 
actin fibers respectively. Scale bars are 50 µm. c) Area and aspect ratio (AR) of cells described in (b), measured using 
ImageJ from at least 30 cells from 3 separate images. Mean +- SD is shown. 
 
CONCLUSIONS 
In summary we synthesized a versatile multiresponsive drug delivery system based on 
thermoresponsive nanogels containing gold nanoparticles for the co-delivery of 
doxorubicin and pomalidomide. The gold nanoparticles inside the nanogel were 
synthesized in a new two-step method to ensure even particle distribution throughout the 
gel and surfactant-free synthesis. The leakage of drugs was reduced by wrapping the 
nanogels with a polyelectrolyte shell. We studied two possible coatings: polyalginate and 
poly-L-arginine. These two coatings produced different modifications in the 
thermoresponsive behavior of the nanogels and other physicochemical properties that were 
characterized and influenced first, the stimuli responsive release of the two drugs and 
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second, their interaction with cells and their drug delivery in vitro We showed that pH, 
glutathione concentration, heat and NIR-light can all trigger the release of drugs in an 
extent that was dependent on the chemical nature of the drug and the coating 
polyelectrolytes. Both coated nanogel systems showed enhanced uptake by cancer cells 
compared to non-cancer cells, due to their enhanced metabolism, but more specific uptake 
in cancer cells was seen for nanogels coated with positively charged polyalginate. Taking 
this into account and considering: 1) both polyelectrolyte coated PEGMA nanogels have 
low leakage and show a slow drug release profile, 2) the cytotoxic doxorubicin is released 
more efficiently by a remote controlled trigger (light) from AuNG3 than AuNG2 nanogels 
and 3) the release of pomalidomide was effective for the two nanogel formulations, we can 
conclude that polyalginate coated PEGMA nanogels can be considered as the more 
convenient drug delivery system for the remote controlled co-delivery of doxorubicin and 
pomalidomide. 
 
 
 
METHODS 
Materials. Milli-Q water (resistivity 18.2 MΩ·cm) was used in all experiments. Hydrogen 
tetrachloroaurate trihydrate (HAuCl4·3H2O, ≥99.9%), di(ethylene glycol) methyl ether 
methacrylate, poly(ethylene glycol) methyl ether methacrylate, poly(ethylene glycol) 
diacrylate, 2-aminoethyl methacrylate hydrochloride, methacrylic acid, formaldehyde (37 
wt%), doxorubicin hydrochloride and poly-L-arginine hydrochloride (mol wt >70,000) 
were all purchased from Sigma-Aldrich. Pomalidomode was purchased from Abcam. 
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Alginic acid (sodium salt) was obtained from Fisher Scientific. All glassware was washed 
with aqua regia, rinsed 3 times with Milli-Q water and dried before use. 
Synthesis of poly ethylene glycol methacrylate nanogel. 
Nanogels were synthesized by purging a 300 mL Milli-Q water solution of 5.6 g 
di(ethylene glycol) methyl ether methacrylate, 2,4 g poly(ethylene glycol) methyl ether 
methacrylate, 160 mg poly(ethylene glycol) diacrylate, 297 mg methacrylic acid and 576 
mg 2-aminoethyl methacrylate hydrochloride with argon for an hour at 70 ºC. The reaction 
was then started by adding 120 mg of 2,2, azobis(2methylpropionamidine)dihydrochloride 
disolved in 2 mL of degassed Milli-Q water and run for 12 hours at 70 ºC.  
Synthesis of AuNP decorated nanogel. 
After washing via centrifugation, 10 mL of nanogels were incubated with 50 µL 0.1 M 
HAuCl4 overnight before reduction of the gold occurs with addition of 100 µL 0.1 M 
NaBH4 solution. Small gold domains of about 3-4 nm were formed and stabilized by the 
amino group of 2-aminoethyl methacrylate hydrochloride. The nanogels were used as seeds 
for the growth of bigger gold particles without further purification. Further growth of AuNP 
was carried out with formaldehyde under basic conditions. A 100 mL growth solution with 
a final concentration of 1 mM HAuCl4, 5 mM NaBr and different amounts of seeds was 
prepared followed by the addition of 500 µL formaldehyde solution (37 wt%). The 
reduction was finally started by changing the pH to 11 through the addition of 750 µL 1 M 
NaOH. The reaction was very slow due to the more stable gold-bromide complexes. After 
15 minutes a color change was observed but the reaction was allowed to run overnight 
before particles were carefully washed via centrifugation and characterized (TEM and UV-
Vis spectroscopy). By simply varying the amount of seeds, AuNP with different sizes were 
obtained.  
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Loading with Doxorubicin/Pomalidomide and addition of polyelectrolyte layer 
Nanogels were loaded with drugs by immersing them in solutions of Doxo and/or Poma 
with a final concentration of 0.25 mM of each drug and a pH adjusted to ca. 8. The 
nanogels were incubated overnight and the addition of the polyelectrolyte layer was carried 
out without further purification. After mixing, the particles were gently shaken and the 
mixture was incubated for 30 min. Nanogels and polyelectrolytes were mixed in a 1:1 
volume ratio. The solutions of polyelectrolytes were prepared with a concentration of 1 
mg/mL poly alginate, 0.5M NaCl adjusted to pH=5 and 0.5 mg/mL poly-L-arginine and 0.5 
M NaCl. Thereafter, nanogels were purified by centrifugation (6 times, 2240 g for 15 min) 
and the supernatants were collected to calculate the loading of every drug by fluorescence 
spectroscopy (Varioskan Flash from Thermo Scientific) and ultra performance liquid 
chromatography (Acquity). 
Drug release via NIR-illumination 
One hundred µL of AuNG samples was placed in a 96-well transparent microplate and 
laser irradiation was carried out using a 808 nm fiber coupled laser diode with a maximum 
power of 4 W (Lumics). The spot size was chosen to iluminate the whole well at once (0.4 
cm in diameter) and the power and time was adjusted to obtain the desired power density 
used for the experiments.  
Co-culture and Live/Dead staining 
Human dermal fibroblast (HDF; Invitrogen) cells were stained in suspension for 1 h, 37 °C, 
using Cell Tracker Blue CMF2HC (Invitrogen) at a final dilution of 1/100 in FBS free 
DMEM. Cells were washed and mixed 1:1 with unstained HeLa cells (a gift from Prof. 
Charles Lawrie, Biodonostia) and plated at a final cell number of 1x104 cells/well in a 96-
well plate (Ibidi µ-plate 96-well). The following day media was replaced with doxorubicin 
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(4 µg/mL; Sigma Aldrich) and nanogel solutions (diluted 1/25, equivalent to 4 µg/mL 
doxorubicin), 200 µL/well. PEGMA nanogels were incubated with cells for 2.5h, followed 
by washing with warm PBS (10 mM, pH 7.4) and replacement of the medium. Images were 
taken at various time points, after removal of nanogel solutions, using a 20× objective with 
DIC contrast and red and blue fluorescence channels for doxorubicin and Cell Tracker Blue 
(HDF cells) fluorescence respectively. A Zeiss Cell Observer microscope with AxioVision 
software was used. 
The same cultures were used to analyze cell viability using Live/Dead (Abcam) staining 
after ca. 96 h. Media was replaced with 150 µl of warmed staining buffer containing 1/1000 
dilutions of both “live” and “dead” fluorophores. Cells were left at 37 °C for 15 min and 
then imaged using a 10× objective with phase contrast and green and red fluorescence 
channels for “live” and “dead” staining respectively. Due to the late timepoint, HDF cells 
were no longer positive for Cell Tracker Blue and therefore visual comparison of cell 
morphology alone was used to differentiate between dead cell populations. A Zeiss Cell 
Observer microscope with AxioVision software was used. 
Flow cytometry 
Human dermal fibroblast cells were stained in suspension for 1 h, 37 °C, using Cell Tracker 
Blue CMF2HC at a final dilution of 1/100 in FBS free DMEM. Cells were washed and 
mixed 1:1 with unstained HeLa cells and plated in a 24-well plate at 5x104cells/well. The 
following day media was replaced with doxorubicin (4 µg/ml) and nanogel solutions 
(diluted 1/25, equivalent to 4 µg/ml doxorubicin), 500 µL/well. PEGMA nanogels were 
incubated with cells for 2h30, followed by washing with warmed PBS (10 mM, pH 7.4) and 
replacement of the media. The following day cells were lifted up using trypsin-EDTA and 
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washed twice with ice-cold PBS. Samples were analysed in 1 % BSA/PBS on a BD Canto 
II flow cytometer using compensation. Cells were gated using the Pacific Blue channel 
(HeLa vs. CMF2HC-stained HDF cells), and then the % of doxorubicin positive cells 
measured in the PE channel.  
Cell viability; irradiation experiments 
HeLa cells were plated in a 96-well TC-treated transparent plate at 5x104 cells/mL, 100 
µL/well. The following day media was replaced with doxorubicin (4 µg/mL) and NP 
solutions (diluted 1/25, equivalent to 4 µg/mL doxorubicin), 100 µL/well. NPs were left 
overnight with cells (approx 18 h) followed by replacement of the cell media. Individual 
wells were irradiated using a 808 nm fiber coupled laser diode with a maximum power of 4 
W (Lumics). The spot size was chosen to illuminate the whole well at once (0.4 cm in 
diameter) and the power and time was adjusted to obtain the desired power density used for 
the experiments. The following day cell viability was analysed using the MTT assay 
(Roche) and absorbance measured at 550 nm, showing both non-irradiated and irradiated 
wells. 
Transmission electron microscopy of cells 
HeLa cells were grown in 60 mm diameter tissue culture treated petri dishes, 1x106 
cells/3 mL/dish. The following day, nanogels were added at a final dilution of 1/50, 3 
ml/dish. PEGMA nanogels were incubated with cells for 2 h, followed by washing with 
warm PBS and replacement of the medium. The day after, cells were fixed in the dish using 
2 % formaldehyde/2.5 % glutaldehyde in Sorensens buffer (initial fixation of 10 min at rt, 
followed by secondary fixation with fresh solution for 2 h at 4°C). Fixative was removed 
and cells washed using cold Sorensens buffer. A cell scrapper was used to bring the cells 
into suspension. Cells were embedded in 2% agar, followed by further fixation and staining 
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with a 1% osmodium tetraoxide solution for 1h on ice. Samples were washed with 
Sorensens buffer and then water, and dehydrated in an ethanol series, followed by 2 final 
pure ethanol and then pure acetone washes. Samples were embedded in Spurrs resin and 
polymerized overnight at 65 °C. One hundred nm slices were cut using an ultramicrotome 
and viewed using TEM (JEOL JEM-1400PLUS , 40kV - 120kV). 
LPS-induced IL-6 production from J774 cells 
J774 macrophages were plated in a normal tissue culture treated 96-well plate at a 
concentration of 2 x 10^5 cells/ml, 100 µl/well. The following day half the wells were pre-
treated with LPS (Sigma Aldrich) at a final concentration of 1 µg/ml, 100 µl/well. After 1 h 
of LPS-stimulation, a further 100 µl of NPs (1/5 diluted, equivalent to a final pomalidomide 
concentration of 10 µM) were added. Controls including free pomalidomide (a final 
pomalidomide concentration of 10 µM), DMSO (final dilution of 1/5000 equivalent to the 
volume present in 10 µM pomalidomide), and pomalidomide free NPs were included. The 
final volume was 200 µl/well. Cells were incubated for 24 h, following which supernatants 
were removed and frozen for subsequent IL-6 analysis. Supernatants were analysed for IL-
6 using standard sandwich ELISA with TMB substrate detection.  
Angiogenesis assays 
Human umbilical vein endothelial cells (HUVEC) were plated in a normal tissue culture 
96-well plate at 1x106 cells/ml, 100 µL/well. The following day nanogels were added at a 
final concentration equivalent to 10 µM pomalidomide. Cells were incubated with PEGMA 
nanogels for 2 h, followed by washing with warmed PBS and replacement of the media. 
The following day 10 µL of Geltrex (Invitrogen) was placed in the lower wells of an 
angiogenesis slide (Ibidi µ-slide Angiogenesis) and left to solidify at 37 °C for 
approximately 30 min. HUVECs, previously incubated with nanogels, were uplifted using 
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Trypsin-EDTA (Invitrogen), counted, and adjusted to 2x105cells/ml. Fifty µL of cells were 
added to each well (1x104cells), taking care not to disturb the gel. Control wells without 
nanogel pre-incubation and with direct pomalidomide (10 µM) incubation were included. 
Cells were imaged approximately 6 h post seeding with a Zeiss Cell Observer microscope 
equipped with a x10 objective with phase contrast. AxioVision software with the “Mosaix” 
application was used to image the whole well (4 mm diameter). 
Pomalidomide-induced cell morphological changes 
HUVEC cells were plated in a 96-well plate (Ibidi µ-plate 96-well) at a concentration of 
4x104 cells/well, 200 µL/well. The following day media was replaced with the 
corresponding nanogel solution, 200 µL/well, at a final concentration equivalent to 10 µM 
pomalidomide. Pomalidomide-free nanogels at an equivalent concentration, and 
pomalidomide alone were also included. After 4 h, wells were washed with warmed PBS 
and fixed using a 4% formaldehyde solution in PBS. Cells were stained using DAPI 
(Invitrogen) and AF488-phalloidin (Invitrogen) to show the nucleus and actin fibers 
respectively. Images were taken using an EC Plan-Neofluar x40 oil objective with DIC 
contrast and filters for green (AF488-phalloidin actin staining), red (doxorubicin staining) 
and blue (DAPI nuclear staining) fluorescence. Cell area and aspect ratio (AR) values were 
calculated using ImageJ, analyzing 10 cells from 3 separate compound images composed of 
9 tiles (in total ca. 30 cells/formulation). 
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